OSE Immunotherapeutics SA (EPA:OSE)
4.752
-0.066 (-1.37%)
At close: Jan 30, 2026
OSE Immunotherapeutics Market Cap
OSE Immunotherapeutics has a market cap or net worth of €106.54 million as of January 30, 2026. Its market cap has decreased by -24.13% in one year.
Market Cap
106.54M
Enterprise Value
114.40M
Revenue
1.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.75
Market Cap Chart
Since March 30, 2015, OSE Immunotherapeutics's market cap has increased from 104.30M to 106.54M, an increase of 2.15%. That is a compound annual growth rate of 0.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 106.54M | -7.73% |
| Dec 31, 2025 | 115.47M | -26.37% |
| Dec 31, 2024 | 156.83M | 94.71% |
| Dec 29, 2023 | 80.55M | -34.73% |
| Dec 30, 2022 | 123.40M | -34.26% |
| Dec 31, 2021 | 187.71M | 45.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genfit | 281.34M |
| Transgene | 251.37M |
| Cellectis | 236.14M |
| Innate Pharma | 145.61M |
| ABIONYX Pharma | 135.11M |
| MaaT Pharma | 123.69M |
| Adocia | 117.95M |
| Sensorion | 112.63M |